Items tagged with Advocacy
Invitation: Participation in community engagement survey (post)
Background & purpose
Aeras global campaign: #TBunmasked (post)
Today we launch #TBunmasked, a global campaign to support the 50 million healthcare workers on the front lines of the global TB epidemic.
Toolkits and materials on community engagement in research (post)
Here is a compilation of materials that cover training, implementation and monitoring and evaluation:
MPP strategic expansion consultancy – tuberculosis (post)
The Medicines Patent Pool (MPP) is seeking proposals from individuals and organisations to assess the feasibility of expanding the mandate of the MPP into tuberculosis (TB). The proposed timeframe for the provision of the consultancy services is 15th November 2014 to 27th February 2015.
First National TB Patient Symposium in Pakistan (post)
A historic event - the First National TB Patient Symposium in Pakistan - will be held on October 23, 2014 at Hotel Margala, Islamabad.
Lithuania hosts a briefing on MDR-TB in Europe for EU member states (post)
On 10 October, prominent speakers were invited to the Lithuanian Permanent Representation to the EU to brief Health Attachés of the different member states’ representations in Brussels on the issue of Tuberculosis and Multidrug-Resistant Tuberculosis in Europe. WHO Europe, the ECDC, the STOP TB Partnership, the TB Europe Coalition, the European Commission and 10 member states (France, Estonia, Bulgaria, Czech Republic, Greece, Croatia, Hungary, Belgium, Latvia and Lithuania) were present to discuss the topic and potential for future EU action. Here is a summary of the main points that were addressed:
Documentary: Fire in the Blood (post)
When big pharma blocks essential HIV/AIDS medication to the third world, it is the poor who suffer.
Advocates protest meetings between pharma lawyers and Indian officials (post)
Patient advocates in India are protesting meetings being held this week between a trade group that advocates for intellectual property rights on behalf of global drug makers and Indian government officials, including leading judges, who decide patent policies and cases.
EECA: Civil society organizations signed an Open Letter addressed to the Global Fund Board pleading to hear their concerns (post)
Earlier this year, the Global Fund started a full roll out of its new funding model. In March 2014 at its Thirty-First Meeting the Global Fund Board approved a new allocation methodology and the funding resources for the 2014 - 2016 allocation period. 24 organizations representing civil society and including communities of people living with HIV, tuberculosis (TB) or Hepatitis C, i.e. key affected populations from Eastern Europe and Central Asia (EECA) and their partner organizations from other regions signed an Open Letter addressed to the Global Fund Board members.
Former MDR-TB patient and TB advocate, Marina, meets with the European Parliament (post)
Between 18th and 19th November, TB Europe Coalition members, RESULTS UK and Global Health Advocates, had the exciting opportunity to welcome Marina to Brussels to brief decision-makers on the severity of the TB epidemic (TB) in the European Union (EU). Marina fought two years to defeat multidrug-resistant TB (MDR-TB) and is now a great advocate on the issue. By bringing the perspective of MDR-TB patients, Marina highlighted the urgent need for action at regional level to fight TB and ensure the rights of TB patients.
Page 4 of 126 · Total posts: 0
←First 3 4 5 Last→